Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.720
0.00 (0.00%)
May 15, 2026, 3:58 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 169.91 million as of May 19, 2026. Its market cap has increased by 29.04% in one year.
Market Cap
169.91M
Enterprise Value
182.23M
Revenue
113.01M
Ranking
n/a
PE Ratio
15.82
Stock Price
1.72
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 169.91M, a decrease of -19.71%. That is a compound annual growth rate of -2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 169.91M | 2.80% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 270.21M |
| TerrAscend | 261.58M |
| Organigram Global | 208.14M |
| Cardiol Therapeutics | 202.49M |
| Auxly Cannabis Group | 200.54M |
| BioSyent | 165.17M |
| HLS Therapeutics | 143.55M |
| Ascend Wellness Holdings | 128.53M |